Mukka Proteins Completes Acquisition of 51% Stake in Delta Marine Products for Strategic Expansion
Mukka Proteins Limited has completed the acquisition of a controlling stake in Delta Marine Products, Partnership Firm. The strategic move was finalized on June 25, 2026, involving an investment amounting to Rs. 11,10,00,000/- (Rupees Eleven Crores Ten Lakhs Only).The company acquired a 51% stake in Delta Marine Products through capital contribution. This acquisition is part of Mukka Proteins Limited's strategic investment plans aimed at expanding its core business and optimizing operational processes. The move seeks to improve production efficiency and achieve broader market reach for the listed entity.
Delta Marine Products, which operates in the manufacturing of fish meal and fish oil, was acquired as a non-related party transaction.
Acquired Entity and Transaction Details
The details regarding Delta Marine Products and the acquisition are summarized below:| Particulars | Details |
|---|---|
| Target Entity Name | Delta Marine Products |
| Industry | Manufacturing of fish meal and fish oil |
| Stake Acquired | 51% |
| Acquisition Cost | Rs. 11,10,00,000/- (by way of capital contribution) |
| Transaction Date | June 25, 2026 |
Financial and Operational Snapshot
Delta Marine Products, incorporated on August 12, 2023, has shown increasing turnover across the past few years. The entity is based in India.The performance metrics for Delta Marine Products are detailed as follows:
| Metric | FY 2024-25 Status |
|---|---|
| Turnover | Rs. 28,16,99,338/- |
| Profit After Tax (PAT) | Rs. (19,72,919/-) |
The turnover history for Delta Marine Products is as follows:
| Period Ending March | Turnover |
|---|---|
| March 2023 | Not Available (NA) |
| March 2024 | Rs. 3,64,15,650/- |
| March 2025 | Rs. 28,16,99,338/- |
MUKKA Stock Price Movement
On Thursday, Mukka Proteins Limited shares slipped by 2.99% to settle at ₹24.32, falling from its previous close of ₹25.10. The stock recorded a trading volume of 176,424 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.